Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface
- PMID: 3882238
- DOI: 10.1016/0092-8674(85)90211-9
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface
Abstract
The influenza A virus M2 protein is expressed abundantly at the cell surface, and in addition to the hemagglutinin (HA) and neuraminidase (NA), is a third virus-specific membrane protein. M2 has an internal hydrophobic membrane anchorage domain and associates with the same cellular membrane fractions as HA and NA. Trypsin treatment of infected cells and immunoprecipitation with site-specific antisera indicate that a minimum of 18 NH2-terminal amino acids of M2 are exposed at the cell surface. Ten NH2-terminal residues are conserved in all strains of influenza A virus for which sequences are available. Antibodies can recognize M2 on the cell surface and therefore it may be an infected-cell surface antigen. We discuss properties of M2 that match it to the elusive major target molecule on influenza A virus-infected cells for cross-reactive cytotoxic T cells.
Similar articles
-
Lateral Organization of Influenza Virus Proteins in the Budozone Region of the Plasma Membrane.J Virol. 2017 Apr 13;91(9):e02104-16. doi: 10.1128/JVI.02104-16. Print 2017 May 1. J Virol. 2017. PMID: 28202765 Free PMC article.
-
Surface expression of influenza virus neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells.Mol Cell Biol. 1985 Sep;5(9):2181-9. doi: 10.1128/mcb.5.9.2181-2189.1985. Mol Cell Biol. 1985. PMID: 3016520 Free PMC article.
-
Immunologic recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells.J Exp Med. 1977 Sep 1;146(3):673-89. doi: 10.1084/jem.146.3.673. J Exp Med. 1977. PMID: 302303 Free PMC article.
-
Influenza virus M2 protein and haemagglutinin conformation changes during intracellular transport.Acta Virol. 1995 Jun;39(3):171-81. Acta Virol. 1995. PMID: 8579000 Review.
-
Progress on adenovirus-vectored universal influenza vaccines.Hum Vaccin Immunother. 2015;11(5):1209-22. doi: 10.1080/21645515.2015.1016674. Hum Vaccin Immunother. 2015. PMID: 25876176 Free PMC article. Review.
Cited by
-
Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus.Nanomedicine (Lond). 2014 Feb;9(2):237-51. doi: 10.2217/nnm.13.58. Epub 2013 Jul 5. Nanomedicine (Lond). 2014. PMID: 23829488 Free PMC article.
-
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.PLoS One. 2013;8(3):e59081. doi: 10.1371/journal.pone.0059081. Epub 2013 Mar 18. PLoS One. 2013. PMID: 23527091 Free PMC article.
-
Electron microscopic evidence for the association of M2 protein with the influenza virion.Arch Virol. 1991;118(3-4):199-207. doi: 10.1007/BF01314030. Arch Virol. 1991. PMID: 2069504
-
Inhibitors of protein glycosylation and glycoprotein processing in viral systems.Pharmacol Ther. 1987;33(2-3):221-86. doi: 10.1016/0163-7258(87)90066-0. Pharmacol Ther. 1987. PMID: 3310033 Free PMC article. Review. No abstract available.
-
Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein.J Virol. 2004 Sep;78(18):9585-91. doi: 10.1128/JVI.78.18.9585-9591.2004. J Virol. 2004. PMID: 15331690 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
